1-2 of 2
Jesper Stentoft, Professor, dr.MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life Outcomes in Newly Diagnosed Chronic Myeloid Leukemia Patients Treated with Dasatinib and Low Dose Pegylated Interferon

Henrik Hjorth-Hansen, MD, Satu Mustjoki, MD PhD, Ulla Olsson-Strömberg, MD PhD, Jesper Stentoft, Professor, dr.MD, Fabio Efficace, PhD, Hemming Johansson, PhD, Yvonne Brandberg, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4260.
https://doi.org/10.1182/blood-2018-99-111714
Published: 2018
Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Trine Alma Knudsen, MD, Dennis Lund Hansen, MD, Lukas Frans Ocias, MD, Ole Weis Bjerrum, MD DMSc, Mette Brabrand, Daniel El Fassi, MD PhD, Mikael Frederiksen, MD, Lasse Kjær, PhD, Thomas Kielsgaard Kristensen, MSc, PhD, Torben A Kruse, Torben Mourits-Andersen, MD, Peter Møller, MD, Ulrik Malthe Overgaard, MD, Marianne Tang Severinsen, MD PhD, Vibe Skov, PhD, Jesper Stentoft, Professor, dr.MD, Jørn Starklint, MD, Karin de Stricker, MSc, PhD, Mads Thomassen, PhD, Thomas Stauffer Larsen, MD PhD, Hans Carl Hasselbalch, Professor, dr.MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 580.
https://doi.org/10.1182/blood-2018-99-111255
Published: 2018